(Q44485636)

3 December 2017

title

Effect of telmisartan on the proteinuria and circadian blood pressure profile in chronic renal patients (English)

1 reference

3 December 2017

0 references

Adamasco Cupisti

1

1 reference

3 December 2017

Giovanni Manca Rizza

2

1 reference

3 December 2017

Claudia D'Alessandro

3

1 reference

3 December 2017

Ester Morelli

4

1 reference

3 December 2017

Giuliano Barsotti

5

1 reference

3 December 2017

language of work or name

1 reference

1 May 2003

1 reference

Biomedicine and Pharmacotherapy

3 December 2017

published in

1 reference

3 December 2017

volume

57

1 reference

3 December 2017

issue

3-4

1 reference

3 December 2017

page(s)

169-172

1 reference

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900013-1

7 January 2021

An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900013-1

7 January 2021

Evaluation of the safety and efficacy of telmisartan and enalapril, with the potential addition of frusemide, in moderate-renal failure patients with mild-to-moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900013-1

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900013-1

7 January 2021

Ambulatory blood pressure monitoring: fancy gadgetry or clinically useful exercise?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900013-1

7 January 2021

Telmisartan: a review of its use in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900013-1

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900013-1

7 January 2021

Efficacy and tolerability of losartan in hypertensive patients with renal impairment. Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900013-1

7 January 2021

Blood pressure variability as an adverse prognostic risk factor in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900013-1

7 January 2021

Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: beyond haemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900013-1

7 January 2021

10.1016/S0753-3322(03)00013-1

Identifiers

DOI

1 reference

3 December 2017

1 reference